MedTrace Logo

Coil Assisted Flow Diversion Safety and Performance Study

NCT04187573 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2024-11-20

Study results available
· View outcomes & findings →

Summary

Cerus Endovascular is sponsoring a prospective, single arm, multi-center study to document the safety and performance of Neqstent in adjunctive therapy.

The purpose of the study is to document safety and performance of the Neqstent in adjunctive therapy in treatment for patients with intracranial aneurysms (IA).

Conditions

  • Intracranial Aneurysm

Interventions

DEVICE

Neqstent

Adjunctive device providing stable aneurysm neck coverage for the placement of embolization coils within the aneurysm sac and long term stable occlusion of the aneurysm.

Sponsors & Collaborators

  • Cerus Endovascular, Inc.

    lead INDUSTRY

Principal Investigators

  • Thomas Liebig, MD · Klinikum der Universität München

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-21
Primary Completion
2022-06-17
Completion
2023-11-01
FDA Device
Yes

Countries

  • Austria
  • Canada
  • Denmark
  • Germany
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04187573 on ClinicalTrials.gov